alantolactone has been researched along with Acute Lymphoid Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Mi, J; Tong, J; Wu, Y; Xu, X; Yan, H; Zhang, C; Zhang, Z | 1 |
1 other study(ies) available for alantolactone and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Targeting non-oncogene ROS pathway by alantolactone in B cell acute lymphoblastic leukemia cells.
Topics: Animals; Apoptosis; B-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Female; Humans; Lactones; Male; Mice; Mice, Inbred NOD; Mice, SCID; Mitochondria; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Cell Culture; Reactive Oxygen Species; Sesquiterpenes, Eudesmane | 2019 |